J. Bluestone
Immunology · 2000–2022
A researcher in the Science corpus: 27 papers; trusts 15 researchers and is trusted by 22 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 283 citations into it; #154 of 2,160 by trust here, #93 by citations
- Oncology — 68 citations into it; #1,428 of 1,698 by trust here, #881 by citations
Whom J. Bluestone trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Q. Tang
- David Klatzmann
- Taku Okazaki
- Shimon Sakaguchi
- G. Freeman
- J. Fontenot
- Arlene H. Sharpe
- A. Abbas
Who trusts J. Bluestone overall
Papers from J. Bluestone's perspective
Ordered by how strongly the researchers J. Bluestone trusts endorse each paper. Same corpus, a different order for every researcher.
- Regulatory T cell lineage specification by the forkhead transcription factor foxp3. (Immunity)
- B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. (Immunity)
- Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice (Nature Immunology)
- Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. (Annual Review of Immunology)
- A function for interleukin 2 in Foxp3-expressing regulatory T cells (Nature Immunology)
- Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo (Nature Immunology)
- Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance (Nature Immunology)
- Multiple immuno-regulatory defects in type-1 diabetes. (Journal of Clinical Investigation)
- CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. (Immunity)
- Human T regulatory cells can use the perforin pathway to cause autologous target cell death. (Immunity)
Their papers
- Innate immunity and intestinal microbiota in the development of Type 1 diabetes (2008) — 1,947 citations
- Multiple early factors anticipate post-acute COVID-19 sequelae (2022) — 994 citations
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins (2015) — 675 citations
- CD28 costimulation: from mechanism to therapy (2016) — 817 citations
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells (2015) — 950 citations
- Human polymorphism at microRNAs and microRNA target sites. (2013) — 605 citations
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis (2013) — 1,087 citations
- Regulatory T cells: recommendations to simplify the nomenclature (2013) — 600 citations
- Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo (2012) — 676 citations
- Control of TH17 cells occurs in the Small Intestine (2011) — 679 citations
- Genetics, pathogenesis and clinical interventions in type 1 diabetes (2010) — 1,267 citations
- Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal (2009) — 653 citations
- Foxp3 instability leads to the generation of pathogenic memory T cells in vivo (2009) — 1,306 citations
- Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways (2008) — 992 citations
- Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. (2008) — 783 citations
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulation (2008) — 1,095 citations
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells (2006) — 2,743 citations
- International trial of the Edmonton protocol for islet transplantation. (2006) — 1,773 citations
- Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice (2006) — 880 citations
- The NOD mouse: a model of immune dysregulation. (2005) — 1,199 citations